Friday, July 10, 2026

pharma · Renal Transplantation · Rheumatoid Arthritis (RA)

Astellas Pharma

Astellas Pharma is a pharma organization headquartered in CN. Primary therapeutic focus areas include Renal Transplantation, Rheumatoid Arthritis (RA), Non-small Cell Lung Cancer, Restless Legs Syndrome, Hot Flashes. Nov

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP HQ
12,378 Employees
NMPA registrant Type
Company details
Status
Public
HQ
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, JP
Employees
12,378
Programs
20
Drugs
12
Patents
25
Clinical program

TRK-100STP (BERASUS LA)

Phase 1 · small molecule · Healthy

TRK-100STP (BERASUS LA) for Healthy is a Phase 1 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).

← All Astellas Pharma Inc projects Phase 1 small molecule completed

Internal code 533-CL-005

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Astellas Pharma Inc
Phase
Phase 1
Modality
small_molecule
Indication
Healthy
Status
completed
Trials
1